Skip to main content

Advertisement

SpringerLink
Log in

Management options for cavernous sinus meningiomas

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Meningiomas involving the cavernous sinus have traditionally posed a major challenge for neurosurgeons and neuro-oncologists. Recent advancements in surgical techniques and radiotherapy have led to new treatment strategies for these difficult tumors. In this article, we review the current literature with respect to treatment options for cavernous sinus meningiomas. Additionally, we review the recent results of our experience at the University of Utah with decompression surgery followed by radiotherapy for cavernous sinus meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Frotscher B (1910) Zur kasuistik der duraendotheliome. Arch Psychiatr Nervenkr 47:196–199. doi:10.1007/BF02322942

    Article  Google Scholar 

  2. Cushing H, Eisenhardt L (1938) Meningiomas: their classification, regional behavior, life history and surgical end results. Charles C Thomas, Springfield

    Google Scholar 

  3. Parkinson D (1965) A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report. J Neurosurg 23:474–483

    PubMed  CAS  Google Scholar 

  4. Dolenc V (1979) Microsurgical removal of large sphenoidal bone meningiomas. Acta Neurochir Suppl (Wien) 28:391–396

    CAS  Google Scholar 

  5. Dolenc V (1989) Anatomy and surgery of the cavernous sinus. Springer-Verlag, New York

    Google Scholar 

  6. Kotapka MJ, Kalia KK, Martinez AJ, Sekhar LN (1994) Infiltration of the carotid artery by cavernous sinus meningioma. J Neurosurg 81:252–255

    PubMed  CAS  Google Scholar 

  7. Larson JJ, van Loveren HR, Balko MG, Tew JM Jr (1995) Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 83:596–599

    PubMed  CAS  Google Scholar 

  8. Sen C, Hague K (1997) Meningiomas involving the cavernous sinus: histological factors affecting the degree of resection. J Neurosurg 87:535–543

    PubMed  CAS  Google Scholar 

  9. Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:222–224

    PubMed  CAS  Google Scholar 

  10. Go RS, Taylor BV, Kimmel DW (1998) The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology 51:1718–1720

    PubMed  CAS  Google Scholar 

  11. Yano S, Kuratsu J (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105:538–543. doi:10.3171/jns.2006.105.4.538

    Article  PubMed  Google Scholar 

  12. Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir (Wien) 142:507–511. doi:10.1007/s007010050463

    Article  CAS  Google Scholar 

  13. Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G (2004) Natural history of conservatively treated meningiomas. Neurology 63:1133–1134

    PubMed  CAS  Google Scholar 

  14. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62–70 (discussion 70–71)

    Article  PubMed  Google Scholar 

  15. Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766–770

    PubMed  CAS  Google Scholar 

  16. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25–28. doi:10.1136/jnnp.68.1.25

    Article  PubMed  CAS  Google Scholar 

  17. Sekhar LN, Sen CN, Jho HD, Janecka IP (1989) Surgical treatment of intracavernous neoplasms: a four-year experience. Neurosurgery 24:18–30. doi:10.1097/00006123-198901000-00004

    Article  PubMed  CAS  Google Scholar 

  18. Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J (2008) Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir (Wien) 150:189–193 (discussion 193)

    Article  CAS  Google Scholar 

  19. Goldberg M, Rappaport ZH (1987) Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy. Isr J Med Sci 23:825–828

    PubMed  CAS  Google Scholar 

  20. Couldwell WT (2006) Asymptomatic meningiomas. J Neurosurg 105:536–537 (discussion 537)

    Article  PubMed  Google Scholar 

  21. Hirsch WL, Sekhar LN, Lanzino G, Pomonis S, Sen CN (1993) Meningiomas involving the cavernous sinus: value of imaging for predicting surgical complications. AJR Am J Roentgenol 160:1083–1088

    PubMed  CAS  Google Scholar 

  22. De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP (1996) Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery 39:915–919 (discussion 919–920)

    Article  PubMed  Google Scholar 

  23. DeMonte F, Smith HK, Al-Mefty O (1994) Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:245–251

    PubMed  CAS  Google Scholar 

  24. Abdel-Aziz KM, Froelich SC, Dagnew E, Jean W, Breneman JC, Zuccarello M, van Loveren HR, Tew JM Jr (2004) Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes. Neurosurgery 54:1375–1383 (discussion 1383–1384)

    Article  PubMed  Google Scholar 

  25. Sekhar LN, Patel S, Cusimano M, Wright DC, Sen CN, Bank WO (1996) Surgical treatment of meningiomas involving the cavernous sinus: evolving ideas based on a ten year experience. Acta Neurochir Suppl (Wien) 65:58–62

    CAS  Google Scholar 

  26. Knosp E, Perneczky A, Koos WT, Fries G, Matula C (1996) Meningiomas of the space of the cavernous sinus. Neurosurgery 38:434–442 (discussion 442–444)

    Article  PubMed  CAS  Google Scholar 

  27. Sindou M, Wydh E, Jouanneau E, Nebbal M, Lieutaud T (2007) Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone. J Neurosurg 107:937–944. doi:10.3171/JNS-07/11/0937

    Article  PubMed  Google Scholar 

  28. Chang SD, Adler JR Jr, Martin DP (1998) LINAC radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg 71:43–50. doi:10.1159/000029647

    Article  PubMed  CAS  Google Scholar 

  29. Iwai Y, Yamanaka K, Ishiguro T (2003) Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517–524 (discussion 523–524)

    Article  PubMed  Google Scholar 

  30. Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD (2002) Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 97:65–72

    PubMed  Google Scholar 

  31. Liscak R, Simonova G, Vymazal J, Janouskova L, Vladyka V (1999) Gamma knife radiosurgery of meningiomas in the cavernous sinus region. Acta Neurochir (Wien) 141:473–480. doi:10.1007/s007010050327

    Article  CAS  Google Scholar 

  32. Roche PH, Regis J, Dufour H, Fournier HD, Delsanti C, Pellet W, Grisoli F, Peragut JC (2000) Gamma knife radiosurgery in the management of cavernous sinus meningiomas. J Neurosurg 93(suppl 3):68–73

    PubMed  Google Scholar 

  33. Shin M, Kurita H, Sasaki T, Kawamoto S, Tago M, Kawahara N, Morita A, Ueki K, Kirino T (2001) Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 95:435–439

    PubMed  CAS  Google Scholar 

  34. Spiegelmann R, Nissim O, Menhel J, Alezra D, Pfeffer MR (2002) Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 51:1373–1379 (discussion 1379–1380)

    Article  PubMed  Google Scholar 

  35. Abeloos L, Levivier M, Devriendt D, Massager N (2007) Internal carotid occlusion following gamma knife radiosurgery for cavernous sinus meningioma. Stereotact Funct Neurosurg 85:303–306. doi:10.1159/000107365

    Article  PubMed  Google Scholar 

  36. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander EIII, Kooy HM, Flickinger JC (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215–221

    PubMed  CAS  Google Scholar 

  37. Leber KA, Bergloff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43–50

    PubMed  CAS  Google Scholar 

  38. Couldwell WT, Cole CD, Al-Mefty O (2007) Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg 106:30–35. doi:10.3171/jns.2007.106.1.30

    Article  PubMed  Google Scholar 

  39. Linskey ME, Davis SA, Ratanatharathorn V (2005) Relative roles of microsurgery and stereotactic radiosurgery for the treatment of patients with cranial meningiomas: a single-surgeon 4-year integrated experience with both modalities. J Neurosurg 102(suppl):59–70

    PubMed  Google Scholar 

  40. Couldwell WT, Kan P, Liu JK, Apfelbaum RI (2006) Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical note. J Neurosurg 105:148–152. doi:10.3171/jns.2006.105.1.148

    Article  PubMed  Google Scholar 

  41. Pamir MN, Kilic T, Bayrakli F, Peker S (2005) Changing treatment strategy of cavernous sinus meningiomas: experience of a single institution. Surg Neurol 64(suppl 2):S58–S66. doi:10.1016/j.surneu.2005.07.053

    Article  PubMed  Google Scholar 

  42. Maruyama K, Shin M, Kurita H, Kawahara N, Morita A, Kirino T (2004) Proposed treatment strategy for cavernous sinus meningiomas: a prospective study. Neurosurgery 55:1068–1075. doi:10.1227/01.NEU.0000140839.47922.5A

    Article  PubMed  Google Scholar 

  43. van Loveren HR, Keller JT, El-Kalliny M, Scodary DJ, Tew JM Jr (1991) The Dolenc technique for cavernous sinus exploration (cadaveric prosection). Technical note. J Neurosurg 74:837–844

    PubMed  Google Scholar 

  44. Jensen RL, Wendland MM, Chern SS, Shrieve DC (2008) Novalis intensity-modulated radiosurgery: methods for pretreatment planning. Neurosurgery 62:A2–A9 (discussion A9–10)

    Article  PubMed  Google Scholar 

  45. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A (2004) Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67:221–226. doi:10.1023/B:NEON.0000021827.85754.8e

    Article  PubMed  Google Scholar 

  46. Newton HB, Scott SR, Volpi C (2004) Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up. Br J Neurosurg 18:495–499

    Article  PubMed  CAS  Google Scholar 

  47. Newton HB, Slivka MA, Stevens C (2000) Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 49:165–170. doi:10.1023/A:1026770624783

    Article  PubMed  CAS  Google Scholar 

  48. Weston GJ, Martin AJ, Mufti GJ, Strong AJ, Gleeson MJ (2006) Hydroxyurea treatment of meningiomas: a pilot study. Skull Base 16:157–160. doi:10.1055/s-2006-949518

    Article  PubMed  Google Scholar 

  49. Fuentes S, Chinot O, Dufour H, Paz-Paredes A, Metellus P, Barrie-Attarian M, Grisoli F (2004) Hydroxyurea treatment for unresectable meningioma. Neurochirurgie 50:461–467. doi:10.1016/S0028-3770(04)98326-9

    Article  PubMed  CAS  Google Scholar 

  50. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861–866

    PubMed  CAS  Google Scholar 

  51. Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE (2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97:341–346

    Article  PubMed  CAS  Google Scholar 

  52. Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, Fahlbusch R (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86:845–852

    Article  PubMed  CAS  Google Scholar 

  53. Ragel BT, Couldwell WT, Wurster RD, Jensen RL (2007) Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus 23(4):E10. doi:10.3171/FOC-07/10/E10

    Article  PubMed  Google Scholar 

  54. Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL (2006) Calcium channel antagonists augment hydroxyurea- and RU486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery 59:1109–1120 (discussion 1120–1121)

    Article  PubMed  Google Scholar 

  55. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508–517

    PubMed  CAS  Google Scholar 

  56. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588–597. doi:10.1002/cncr.22441

    Article  PubMed  CAS  Google Scholar 

  57. Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, Yung WK (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 40:271–275. doi:10.1097/00006123-199702000-00007

    Article  PubMed  CAS  Google Scholar 

  58. Koper JW, Zwarthoff EC, Hagemeijer A, Braakman R, Avezaat CJ, Bergstrom M, Lamberts SW (1991) Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 27:416–419

    PubMed  CAS  Google Scholar 

  59. Wober-Bingol C, Wober C, Marosi C, Prayer D (1995) Interferon-alfa-2b for meningioma. Lancet 345:331. doi:10.1016/S0140-6736(95)90326-7

    Article  PubMed  CAS  Google Scholar 

  60. Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol 66:155–166. doi:10.1023/B:NEON.0000013498.19981.55

    Article  PubMed  Google Scholar 

  61. Chamberlain MC, Glantz MJ, Fadul CE (2007) Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 69:969–973. doi:10.1212/01.wnl.0000271382.62776.b7

    Article  PubMed  CAS  Google Scholar 

  62. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865–1874

    PubMed  CAS  Google Scholar 

  63. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA (2008) New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol 86:109–122. doi:10.1007/s11060-007-9434-z

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We thank Kristin Kraus, M.Sc., for editorial assistance in preparing this paper.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Utah, 175 N. Medical Drive East, Salt Lake City, UT, 84132, USA

    Michael T. Walsh & William T. Couldwell

Authors
  1. Michael T. Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William T. Couldwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William T. Couldwell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walsh, M.T., Couldwell, W.T. Management options for cavernous sinus meningiomas. J Neurooncol 92, 307–316 (2009). https://doi.org/10.1007/s11060-009-9824-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9824-5

Keywords

Search

Navigation